Clinical Trial Update: The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update examining relationships between neuropsychological testing and imaging modalities in Alzheimer and Parkinson diseases; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Parkinson Disease

Snippet

Sponsor: Aaron Ritter, MD | Conditions: Alzheimer Disease, Parkinson Disease | Phase 2 | Status: TERMINATED | Results posted: 2023-05-24